TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Histopathological biopsy results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of EGFR mutated patients for phenotypic characterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in interleukin-25 transcript expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cumulative reinfection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease in Maternal Stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Drawing skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative abundance of Parabacteroides genus in intestinal microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of uncontrolled expiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of individuals that complied with treatment/intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of frequency individuals successfully used the protein tracking app
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of physical therapy visits attended by individuals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage counseling sessions attended by individuals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Biochemically Verified Alcohol Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Biochemically Verified Tobacco Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Treatment Emergent Adverse Events (AEs) and Serious AEs (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Permanent Discontinuation From Study or Study Intervention Due to Adverse Events and Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Plasma Concentration (Cmax) of PF-07321332 (Nirmatrelvir)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in Diastolic Blood Pressure From Baseline to 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in the Proportion of Patients With Systolic Blood Pressure Less Than or Equal to 140
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: First bowel sound time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: First gas output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: First defecation output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Difference in VAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity (Se)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive Precision (Acc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pill count adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cumulative rate of PONV
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of CRS events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of ICANS events
Endpoint domain: Adverse events/effects
Primary endpoint: Success of mandibular inferior alveolar nerve block anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with LDL-C maintenance <100
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tolebrutinib AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: M2 AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC functional limitation score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of perineal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative blood loss ≥ 500ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: cumulative blood loss ≥ 1000ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: CYP activity measured with metabolic ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DNA sequence mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of total Tau proteins in basal tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Concentration of phosphorylated Tau proteins in basal tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Concentration of Amyloid β 1-40 proteins in basal tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Concentration of Amyloid β 1-42 in basal tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Lipids in basal tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolites in basal tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial Vaginosis Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Canadian Occupational Performance Measure (COPM) Performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Canadian Occupational Performance Measure (COPM) Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participation Strategies Self-Efficacy Scale (PS-SES)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Infant device tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge Level of Mothers on Newborn Bathing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Anxiety level of women
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Womens bonding levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive function measured by MoCA
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Scent Experience Questionnaire (SEQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy of Lanreotide ATG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TCCD normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Parts I-III
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Atrial fibrillation, atrial flutter, or atrial tachycardia events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mechanical power value in optimum PEEP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anastomotic blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reproducibility of visual score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety by Common Terminology Criteria for Adverse Events (CTCAE) V5.0
Endpoint domain: Adverse events/effects
Primary endpoint: Child Neglect and Abuse Awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative level of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in serum albumin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in the QTc interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in Montreal Cognitive Assessment (MoCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: EEG Alpha spectral power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diagnostic performance (sensitivity and specificity) of F-choline PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse reaction to the F-choline injection
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with an SIC at 60 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve From Time 0 Extrapolated to Infinity (AUCinf) of ARV-471
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of ARV-471
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Profile From Time 0 to 120 Hours (AUC120) of ARV-473
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of ARV-473
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in frequency of moderate to severe VMS from Baseline to Week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in frequency of moderate to severe VMS from Baseline to Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in severity of moderate to severe VMS from Baseline to Week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in severity of moderate to severe VMS from Baseline to Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infant-Toddler Social and Emotional Assessment (ITSEA)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ESAS-TSDS score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Weekly change in binge eating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in waist-to-height ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of SNV1521
Endpoint domain: Adverse events/effects
Primary endpoint: Tolerability of SNV1521
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline Quick Form of the Disabilities of the Shoulder and Hand scores at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Boston Carpal Tunnel Questionnaire scores at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory symptoms: EXACT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pre-bronchodilator FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PERG Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PERG Latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Secondary Surgical Interventions
Endpoint domain: Adverse events/effects
Primary endpoint: Change in percentage atheroma volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Child Oral and Motor Proficiency Scale (ChOMPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastrointestinal severity symptom index (GSSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Bone material strength index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volumetric BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disappearance of the reticular vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Safety of implantation of the Hemi verse shoulder prosthesis
Endpoint domain: Adverse events/effects
Primary endpoint: Patient-Reported Dyspnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants with Acceptable OCT Image Quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of NT-proBNP < 5314pg/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Range of NT-proBNP values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients recruited and imaged
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Treatment effective rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volumetric changes during wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of VRC01.23LS
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of device-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of device use in the Clinical Environment as assessed by User Survey
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in postoperative treatment strategy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants identified with pre-diabetes/type 2 diabetes mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Integrity rate of the multi-view acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative coincidence rate congenital heart disease screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive coincidence rate of congenital heart disease screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coincidence rate of multidisciplinary consultation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of bacteria after caries treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of bacteria after caries treatment and fumigation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Anterior pelvic tilting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle Length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in the alcohol cue-induced BOLD signal in the lateral prefrontal cortex (PFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average number of no heavy drinking days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in patient's self-assessed quality of life (by the SF-36 Questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Scapular position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HF symptom by application scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HF symptom by questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incidence of cardiac arrest during intubation
Endpoint domain: Mortality/survival
Primary endpoint: severe hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Urine aldosterone/cortisol ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Depression rating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Depression self rating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of subjects with platelet count increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Sexual Health Knowledge Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Sexual Health Attitudes: Confidence in Ability to Discuss
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Sexual Counseling Skills: Interpersonal Communications
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Ratio of judged-time-to-collision to actual-time-to-collision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Employment Tenure
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in symptoms using the Structured Interview for DSM-IV Personality Disorders (SIDP-IV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in suicidality using the Suicidal Ideation Questionnaire (SIQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in emotion regulation using the Difficulties in Emotion Regulation Scale (DERS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: UWDRS scales
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24h urine copper
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Northwick Park Neck Pain Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mobility with a goniometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective pain measurement with a dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Guideline Adherent Opioid Prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Early postoperative recovery results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Late postoperative recovery results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of pathological examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Speaking-Induced Suppression (SIS) Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Knowledge at 9 months
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Skills at 9 months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Advocacy at 9 months
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: FGFR mutations in bladder cancer tissues and urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Oral Tolerance as Assessed by Clinical Examinations of Oral Hard and Soft Tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year overall survival after surgery
Endpoint domain: Mortality/survival
Primary endpoint: 1-year disease-free survival after surgery
Endpoint domain: Mortality/survival
Primary endpoint: 1-year recurrence-free survival after surgery
Endpoint domain: Mortality/survival
Primary endpoint: Average of the three M1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of transcutaneous cerebral mixed oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost-benefit reinforcement learning performance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: MDS UPDRS IV score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapeutic failure of high flow nasal cannula
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Net Gastrointestinal absorption of food-bound oxalate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Neuropsychiatric Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Predictive level of PCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive level of CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occupational Sitting And Physical Activity Questionnaire (OSPAQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: International physical activity questionnaire short form
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Identification completeness of annotated images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception differences
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Learning efficacy difference
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pain therapy effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single-procedure freedom from AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of Voice-Related Quality of Life (V-RQOL) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in audiometric recording data of subject's speech
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SARS-CoV-2 Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SNOT-22 score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Interstitial Cystitis Symptom Index (ICSI) Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes